Runlin Yang

1.3k total citations
48 papers, 1.1k citations indexed

About

Runlin Yang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Runlin Yang has authored 48 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Runlin Yang's work include Radiopharmaceutical Chemistry and Applications (8 papers), Peptidase Inhibition and Analysis (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Runlin Yang is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (8 papers), Peptidase Inhibition and Analysis (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Runlin Yang collaborates with scholars based in China, Fiji and Poland. Runlin Yang's co-authors include Donghui Pan, Min Yang, Junjie Yan, Yuping Xu, Lizhen Wang, Xinyu Wang, Jie Sheng, Yuping Xu, Yuedi Ding and Lizhen Wang and has published in prestigious journals such as PLoS ONE, Chemistry of Materials and Brain Research.

In The Last Decade

Runlin Yang

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runlin Yang China 20 391 238 216 172 168 48 1.1k
Guixiang Zhang China 21 444 1.1× 111 0.5× 264 1.2× 68 0.4× 133 0.8× 83 1.4k
Lynlee L. Lin Australia 16 482 1.2× 197 0.8× 427 2.0× 88 0.5× 85 0.5× 41 1.7k
Behrooz Johari Iran 23 498 1.3× 105 0.4× 413 1.9× 284 1.7× 140 0.8× 72 1.3k
Dipesh Baradia India 13 650 1.7× 107 0.4× 290 1.3× 243 1.4× 132 0.8× 16 1.4k
Juliette Vergnaud France 22 676 1.7× 129 0.5× 312 1.4× 118 0.7× 56 0.3× 46 1.3k
Sushilkumar Patil India 16 712 1.8× 118 0.5× 323 1.5× 286 1.7× 147 0.9× 19 1.6k
Kyoung Ah Min South Korea 24 526 1.3× 168 0.7× 356 1.6× 84 0.5× 79 0.5× 67 1.4k
Zhirong Zhong China 24 766 2.0× 134 0.6× 350 1.6× 128 0.7× 83 0.5× 59 1.7k
Hongli Chen China 21 377 1.0× 68 0.3× 122 0.6× 113 0.7× 156 0.9× 92 1.3k

Countries citing papers authored by Runlin Yang

Since Specialization
Citations

This map shows the geographic impact of Runlin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runlin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runlin Yang more than expected).

Fields of papers citing papers by Runlin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runlin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runlin Yang. The network helps show where Runlin Yang may publish in the future.

Co-authorship network of co-authors of Runlin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Runlin Yang. A scholar is included among the top collaborators of Runlin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runlin Yang. Runlin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Bin, Runlin Yang, Muhammad Sohail, et al.. (2022). CRISPR/Cas14 provides a promising platform in facile and versatile aptasensing with improved sensitivity. Talanta. 254. 124120–124120. 51 indexed citations
2.
Yao, Bo, Jing Zhang, Zhenqiang Fan, et al.. (2021). Rational Engineering of the DNA Walker Amplification Strategy by Using a Au@Ti3C2@PEI-Ru(dcbpy)32+ Nanocomposite Biosensor for Detection of the SARS-CoV-2 RdRp Gene. ACS Applied Materials & Interfaces. 13(17). 19816–19824. 71 indexed citations
3.
Gao, Lifang, Xu Zhang, Runlin Yang, et al.. (2021). Time-resolved fluorescence determination of albumin using ZnGeO:Mn luminescence nanorods modified with polydopamine nanoparticles. Microchimica Acta. 188(12). 429–429. 1 indexed citations
4.
Xu, Yuping, Lizhen Wang, Donghui Pan, et al.. (2020). Synthesis of a novel 89Zr-labeled HER2 affibody and its application study in tumor PET imaging. EJNMMI Research. 10(1). 58–58. 16 indexed citations
5.
Dosani, Maryam, Runlin Yang, Don Wilson, et al.. (2019). Metabolic Tumour Volume Is Prognostic in Patients with Non-Small-Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy. Current Oncology. 26(1). 57–63. 22 indexed citations
6.
Wang, Lizhen, Yu Liu, Yuping Xu, et al.. (2018). Age-related change of GLP-1R expression in rats can be detected by [18F]AlF-NOTA-MAL-Cys39-exendin-4. Brain Research. 1698. 213–219. 11 indexed citations
7.
Xu, Yuping, Donghui Pan, Lizhen Wang, et al.. (2017). PET of HER2 Expression with a Novel 18FAl Labeled Affibody. Journal of Cancer. 8(7). 1170–1178. 28 indexed citations
8.
Yang, Runlin, Ping Liu, Donghui Pan, et al.. (2016). An Investigation on a Novel Anti-tumor Fusion Peptide of FSH33-53-IIKK. Journal of Cancer. 7(8). 1010–1019. 2 indexed citations
9.
Luo, Jia, Linyuan Shen, Runlin Yang, et al.. (2015). Estimation of Growth Curves and Suitable Slaughter Weight of the Liangshan Pig. Asian-Australasian Journal of Animal Sciences. 28(9). 1252–1258. 26 indexed citations
10.
Liu, Qinghua, Donghui Pan, Chao Cheng, et al.. (2015). Targeting of MMP2 activity in malignant tumors with a 68 Ga-labeled gelatinase inhibitor cyclic peptide. Nuclear Medicine and Biology. 42(12). 939–944. 11 indexed citations
11.
Xu, Qing, Chen Zhu, Yuping Xu, et al.. (2015). Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET. Journal of drug targeting. 23(9). 813–820. 31 indexed citations
12.
Darwish, Mona, Mark Bond, Runlin Yang, Edward T. Hellriegel, & Philmore Robertson. (2015). Evaluation of Potential Pharmacokinetic Drug-Drug Interaction between Armodafinil and Aripiprazole in Healthy Adults. Pharmacopsychiatry. 48(04/05). 170–175. 5 indexed citations
13.
Liu, Qinghua, Donghui Pan, Chao Cheng, et al.. (2015). Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging. PLoS ONE. 10(11). e0141668–e0141668. 11 indexed citations
14.
Deng, Lili, Yuedi Ding, Ying Peng, et al.. (2014). γ-Tocotrienol protects against ovariectomy-induced bone loss via mevalonate pathway as HMG-CoA reductase inhibitor. Bone. 67. 200–207. 47 indexed citations
15.
Xu, Yuping, Donghui Pan, Qing Xu, et al.. (2014). Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe 18F-FBEM–Cys39-exendin-4. Journal of Cancer Research and Clinical Oncology. 140(9). 1479–1488. 20 indexed citations
16.
Xu, Yuping, Donghui Pan, Chen Zhu, et al.. (2014). Pilot Study of a Novel 18F-labeled FSHR Probe for Tumor Imaging. Molecular Imaging and Biology. 16(4). 578–585. 32 indexed citations
17.
Zhang, Kai, Ke Wang, Minhao Xie, et al.. (2013). DNA-templated silver nanoclusters based label-free fluorescent molecular beacon for the detection of adenosine deaminase. Biosensors and Bioelectronics. 52. 124–128. 34 indexed citations
18.
Ding, Yuedi, Jun Fan, Wenxin Li, et al.. (2013). The Effect of Albumin Fusion Patterns on the Production and Bioactivity of the Somatostatin-14 Fusion Protein in Pichia pastoris. Applied Biochemistry and Biotechnology. 170(7). 1637–1648. 7 indexed citations
19.
Tang, Dong, et al.. (2012). Prognostic significance of NSE mRNA in advanced NSCLC treated with gefitinib. Clinical & Translational Oncology. 15(5). 384–390. 7 indexed citations
20.
Wang, Ke, Runlin Yang, Juan Xu, et al.. (2011). DEVELOPMENT OF AN ALPHASCREEN-BASED HIGH-THROUGHPUT SCREENING ASSAY FOR INHIBITORS OF HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3. Journal of Immunoassay and Immunochemistry. 32(3). 219–232.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026